Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Abstract

To investigate the association between serum calcium and risk of breast cancer using a large cohort and a systematic review with meta-analysis. From the Swedish Apolipoprotein Mortality Risk (AMORIS) Study we included 229,674 women who had baseline measurements of serum total calcium and albumin. Multivariable Cox regression was used to assess the association between total and albumin-corrected calcium and breast cancer risk. For the systematic review, an electronic search of MEDLINE and EMBASE databases was performed to identify other prospective cohorts assessing the relationship between serum calcium and breast cancer risk. We pooled the results of our AMORIS cohort with other eligible studies in a meta-analysis using a random effects model. I2 test was used to assess heterogeneity. In the AMORIS study, 10,863 women were diagnosed with breast cancer (mean follow-up: 19 years). We found an inverse association between total serum calcium and breast cancer when comparing the fourth quartile to the first quartile (HR: 0.94, 95% CI: 0.88–0.99, p value for trend 0.04) and similar results using albumin-corrected calcium. In the systematic review, we identified another two prospective cohorts evaluating pre-diagnostic serum total calcium and breast cancer. Combining these studies and our findings in AMORIS in a meta-analysis showed a protective effect of serum calcium against breast cancer, with a summary RR of 0.80 (95% CI: 0.66–0.97). No substantial heterogeneity was observed. Our findings in AMORIS and the meta-analysis support an inverse association between serum calcium and breast cancer risk, which warrants mechanistic investigations.

Vitamin D: And its role in breast cancer

“…It is possible that vitamin D plays a role in controlling normal breast cell growth and has the capacity to stop the growth of cancer cells in this location. This protective effect is believed to be largely supported by the chemopreventive actions of 1,25‐hydroxyvitamin D (1.25OH2D, or calcitriol), the bioactive form of vitamin D, a well‐known calcium regulator [19].…”

Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study

“…The mechanism(s) underlying this surprising finding is not known. However, a recent meta-analysis reported an inverse association between calcium and subsequent breast cancer risk in prospective cohorts, and the results did not alter when they restricted the analyses to participants with calcium levels within the normal range (41). There is also several mechanisms by which cancer can cause low serum PTH in cancer subjects (42).…”

Circulating concentrations of micro-nutrients and risk of breast cancer: A Mendelian randomization study

“…0.66 to 0.97, per 1 mmol/L increase in serum calcium) [60]. In addition, the third expert report from WCRF also reported an inverse association of dietary calcium with pre-menopausal (relative risk [RR] for 300mg/day increase of dietary calcium intake: 0.87, 95% CI: 0.76 to 0.99) and post-menopausal breast cancer (RR: 0.96, 95% CI:…”